[Association of left bundle branch block definitions with response to cardiac resynchronisation therapy in patients

V A Kuznetsov1, L M Malishevskii1, V V Todosiychuk1

  • 1Tomsk National Research Medical Center of the Russian Academy of Sciences, Tyumen Cardiology Research Center, Tomsk, Russia.

Kardiologiia
|November 6, 2020
PubMed

Insights

Different criteria for complete left bundle branch block (cLBBB) impact prediction of reverse left ventricular remodeling after cardiac resynchronization therapy (CRT). Strauss criteria showed highest sensitivity, while AHA and RAFT criteria offered the best specificity for predicting CRT response.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Imaging

Background:

  • Complete left bundle branch block (cLBBB) is a key indicator for cardiac resynchronization therapy (CRT).
  • Predicting reverse left ventricular (LV) remodeling post-CRT is crucial for patient outcomes.
  • Various diagnostic criteria exist for identifying cLBBB, potentially impacting treatment prediction.

Purpose of the Study:

  • To compare the diagnostic significance of different cLBBB criteria in predicting reverse LV remodeling.
  • To evaluate the effectiveness of various cLBBB criteria in identifying patients who will benefit from CRT.

Main Methods:

  • Ninety-three patients undergoing CRT were analyzed.
  • Left ventricular end-systolic volume (LV ESV) changes determined CRT response (responders vs. non-responders).
  • Nine different criteria for cLBBB diagnosis were assessed, including those from major clinical guidelines (AHA, ESC) and large multicenter studies (MADIT-CRT, REVERSE, RAFT).

Main Results:

  • Incidence of cLBBB was significantly higher in CRT responders across multiple criteria (AHA, ESC 2013, Strauss, MADIT-CRT, REVERSE, RAFT).
  • The Strauss criterion demonstrated the highest sensitivity (80.3%) and overall accuracy (72.04%).
  • AHA and RAFT criteria exhibited the highest specificity (92.6%). Clinical guideline criteria (AHA, ESC 2013) showed strong consistency (κ=0.818).

Conclusions:

  • The diagnostic criteria used for cLBBB influence the prediction of reverse LV remodeling following CRT.
  • While guideline criteria (AHA, ESC 2013) and Strauss criteria are effective, they vary in sensitivity and specificity.
  • Inconsistencies in cLBBB criteria used in large multicenter studies necessitate careful interpretation of their findings.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
168
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
243
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
586
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
129
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
157
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
275